Q3 2022 Evoke Pharma Inc Earnings Call Transcript
Good afternoon, and welcome to the Evoke Pharma's third-quarter 2022 earnings conference call. (Operator Instructions) Be advised that today's call is being recorded.
I will now turn the call over to Daniel Kontoh-Boateng. Thank you. You may begin.
Good afternoon, and thank you for participating in Evoke Pharma's conference call today. With me today are David Gonyer, Evoke's Chief Executive Officer; Chris Quesenberry, Gimoti's Chief Commercial Officer from EVERSANA; and Matthew D'Onofrio, Evoke's Chief Business Officer.
By now, you should have a copy of the press release we issued earlier. If not, it is available on the Investor Relations page of our website at evokepharma.com. We encourage everyone to read today's press release as well as Evoke's quarterly report on Form 10-Q, which is now filed with the SEC. The company's 10-Q report and press release are also available on Evoke's website.
Please note that certain information discussed on the call today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |